TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
VNDA

Vanda Pharmaceuticals Inc

Healthcare · Biotechnology

3.80$ -6.4% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Vanda Pharmaceuticals Inc (VNDA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.4% of the shares are freely tradable; institutional investors hold 78.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 78.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 77.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 13.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 61Mio.

Largest Shareholders

Institutions

Institutions VNDA
Name Stake (%) Shares Change (%) Date
BlackRock Inc 12.66 7,653,737 +5.2 06/30/2026
State Street Corp 5.82 3,516,405 +16.6 06/30/2026
AQR Capital Management LLC 5.78 3,497,695 +118.1 06/30/2026
Renaissance Technologies Corp 5.69 3,441,361 -8.5 06/30/2026
Vanguard Capital Management, LLC 4.17 2,524,040 +1.7 06/30/2026
AIGH Capital Management, LLC 3.38 2,044,169 -25.7 06/30/2026
Acadian Asset Management LLC 3.17 1,918,063 +6.8 06/30/2026
Dimensional Fund Advisors, Inc. 2.86 1,727,349 -2.5 06/30/2026

Funds

Funds VNDA
Name Stake (%) Shares Change (%) Date
State Street® SPDR® S&P® Biotech ETF 2.98 1,800,446 -1.9 09/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.91 1,761,840 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?